Evidence map›Paper›PMID 32443527›Full record

ReviewMolecules (Basel, Switzerland)2020

Mechanisms Regulating the UPS-ALS Crosstalk: The Role of Proteaphagy.

Grégoire Quinet, Maria Gonzalez-Santamarta, Clara Louche, Manuel S Rodriguez

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. When autophagy meets placenta development and pregnancy complications.Frontiers in cell and developmental biology · 2024
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Grégoire QuinetITAV-CNRS USR 3505 IPBS-UPS, 1 place Pierre Potier, 31106 Toulouse, France.
Maria Gonzalez-SantamartaITAV-CNRS USR 3505 IPBS-UPS, 1 place Pierre Potier, 31106 Toulouse, France.
Clara LoucheITAV-CNRS USR 3505 IPBS-UPS, 1 place Pierre Potier, 31106 Toulouse, France.
Manuel S RodriguezITAV-CNRS USR 3505 IPBS-UPS, 1 place Pierre Potier, 31106 Toulouse, France.ORCID 0000-0001-5445-4495

Funding

Consejo Nacional de Ciencia y Tecnología 0280365H2020 Marie Skłodowska-Curie Actions 765445Institut National Du Cancer PLBIO16-251Région Occitanie Pyrénées-Méditerranée REPERE and Pre-maturation programs
6 · The paper itself

Abstract

Protein degradation is tightly regulated inside cells because of its utmost importance for protein homeostasis (proteostasis). The two major intracellular proteolytic pathways are the ubiquitin-proteasome and the autophagy-lysosome systems which ensure the fate of proteins when modified by various members of the ubiquitin family. These pathways are tightly interconnected by receptors and cofactors that recognize distinct chain architectures to connect with either the proteasome or autophagy under distinct physiologic and pathologic situations. The degradation of proteasome by autophagy, known as proteaphagy, plays an important role in this crosstalk since it favours the activity of autophagy in the absence of fully active proteasomes. Recently described in several biological models, proteaphagy appears to help the cell to survive when proteostasis is broken by the absence of nutrients or the excess of proteins accumulated under various stress conditions. Emerging evidence indicates that proteaphagy could be permanently activated in some types of cancer or when chemoresistance is observed in patients.

Indexed as

AutophagyCell Physiological PhenomenaHumansLysosomesMacroautophagyProteasome Endopeptidase ComplexProteolysisUbiquitinUbiquitinationProteasome Endopeptidase ComplexUbiquitinautophagypathologyproteaphagyubiquitin-likeubiquitin proteasome system

Identifiers

PMID32443527
PMCPMC7288101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.